Skandinaviska Enskilda Banken (SEB)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,200
| Closed | -$671K | – | 934 |
|
|
2023
Q4 | $671K | Hold |
23,200
| – | – | ﹤0.01% | 744 |
|
|
2023
Q3 | $639K | Sell |
23,200
-4,700
| -17% | -$129K | ﹤0.01% | 736 |
|
|
2023
Q2 | $840K | Buy |
+27,900
| New | +$840K | 0.01% | 725 |
|
|
2020
Q4 | – | Sell |
-7,000
| Closed | -$146K | – | 1158 |
|
|
2020
Q3 | $146K | Buy |
+7,000
| New | +$146K | ﹤0.01% | 921 |
|
|
2020
Q1 | – | Sell |
-75,100
| Closed | -$1.78M | – | 938 |
|
|
2019
Q4 | $1.78M | Buy |
75,100
+4,200
| +6% | +$99.6K | 0.01% | 587 |
|
|
2019
Q3 | $1.95M | Sell |
70,900
-100
| -0.1% | -$2.75K | 0.02% | 552 |
|
|
2019
Q2 | $2.35M | Sell |
71,000
-9,700
| -12% | -$321K | 0.02% | 465 |
|
|
2019
Q1 | $2.83M | Buy |
80,700
+5,600
| +7% | +$196K | 0.03% | 391 |
|
|
2018
Q4 | $2.5M | Sell |
75,100
-2,200
| -3% | -$73.1K | 0.02% | 412 |
|
|
2018
Q3 | $3.89M | Buy |
77,300
+26,200
| +51% | +$1.32M | 0.03% | 342 |
|
|
2018
Q2 | $3.06M | Sell |
51,100
-13,400
| -21% | -$802K | 0.03% | 347 |
|
|
2018
Q1 | $2.95M | Sell |
64,500
-14,600
| -18% | -$669K | 0.03% | 304 |
|
|
2017
Q4 | $3.15M | Buy |
+79,100
| New | +$3.15M | 0.03% | 351 |
|
|
2016
Q4 | – | Sell |
-96,200
| Closed | -$2.38M | – | 732 |
|
|
2016
Q3 | $2.38M | Sell |
96,200
-142,500
| -60% | -$3.52M | 0.03% | 426 |
|
|
2016
Q2 | $4.86M | Sell |
238,700
-65,400
| -22% | -$1.33M | 0.05% | 254 |
|
|
2016
Q1 | $4.64M | Sell |
304,100
-104,600
| -26% | -$1.6M | 0.05% | 256 |
|
|
2015
Q4 | $5.49M | Buy |
+408,700
| New | +$5.49M | 0.07% | 202 |
|